Maternal RANKL Reduces the Osteopetrotic Phenotype of Null Mutant Mouse Pups

Maternal RANKL Reduces the Osteopetrotic Phenotype of Null Mutant Mouse Pups

RANKL signalization is implicated in the morphogenesis of various organs, including the skeleton. Mice invalidated for <i>Rankl</i> present an osteopetrotic phenotype that was less severe than anticipated, depending on RANKL’s implication in morphogenesis. The hypothesis of an...

Full description

Bibliographic Details
Main Authors:	Benjamin Navet, Jorge William Vargas-Franco, Andrea Gama, Jérome Amiaud, Yongwon Choi, Hideo Yagita, Christopher G. Mueller, Françoise Rédini, Dominique Heymann, Beatriz Castaneda, Frédéric Lézot
Format:	Article
Language:	English
Published:	MDPI AG 2018-11-01
Series:	Journal of Clinical Medicine
Subjects:	RANKL skeletal growth morphogenesis osteoclast bone mandible tooth
Online Access:	https://www.mdpi.com/2077-0383/7/11/426

Similar Items

The Intrinsic and Extrinsic Implications of RANKL/RANK Signaling in Osteosarcoma: From Tumor Initiation to Lung Metastases
by: Benjamin Navet, et al.
Published: (2018-10-01)

LAMP-2 Is Involved in Surface Expression of RANKL of Osteoblasts In Vitro
by: Ineke D.C. Jansen, et al.
Published: (2020-08-01)

Origins of Alterations to <i>Rankl</i> Null Mutant Mouse Dental Root Development
by: Andrea Gama, et al.
Published: (2020-03-01)

Osteoclast activity in osteoporosis mandibular bone based on RANKL and osteoprotegerin ratio.
by: Mefina Kuntjoro, et al.
Published: (2021-11-01)

Niclosamide and its derivative DK‐520 inhibit RANKL‐induced osteoclastogenesis
by: Yurui Jiao, et al.
Published: (2020-08-01)

The participation of RANK, RANKL and OPG in tumor osteolysis
by: Marcin Stanisławowski, et al.
Published: (2009-05-01)

Zoledronate Enhances Osteocyte-Mediated Osteoclast Differentiation by IL-6/RANKL Axis
by: Hyung Joon Kim, et al.
Published: (2019-03-01)

Primary Retention of Molars and RANKL Signaling Alteration during Craniofacial Growth
by: Andrea Gama, et al.
Published: (2020-03-01)

Sitagliptin, An Anti-diabetic Drug, Suppresses Estrogen Deficiency-Induced OsteoporosisIn Vivo and Inhibits RANKL-Induced Osteoclast Formation and Bone Resorption In Vitro
by: Chuandong Wang, et al.
Published: (2017-06-01)

The Effects of Aronia melanocarpa ‘Viking’ Extracts in Attenuating RANKL-Induced Osteoclastic Differentiation by Inhibiting ROS Generation and c-FOS/NFATc1 Signaling
by: Mithun Ghosh, et al.
Published: (2018-03-01)

Effect of TNF-α on osteocyte RANKL expression during orthodontic tooth movement
by: Aseel Marahleh, et al.
Published: (2021-10-01)

A novel RANKL‐targeted flavonoid glycoside prevents osteoporosis through inhibiting NFATc1 and reactive oxygen species
by: Guoju Hong, et al.
Published: (2021-05-01)

Piceatannol attenuates RANKL-induced osteoclast differentiation and bone resorption by suppressing MAPK, NF-κB and AKT signalling pathways and promotes Caspase3-mediated apoptosis of mature osteoclasts
by: Liuliu Yan, et al.
Published: (2019-06-01)

Substance P participates in periodontitis by upregulating HIF-1α and RANKL/OPG ratio
by: Kaixian Yan, et al.
Published: (2020-01-01)

The RANKL expression and osteoclast in alveolar bone of rat diabetic model at different mechanical force application
by: Nuzulul Hikmah, et al.
Published: (2018-03-01)

Asiatic Acid Inhibits OVX-Induced Osteoporosis and Osteoclastogenesis Via Regulating RANKL-Mediated NF-κb and Nfatc1 Signaling Pathways
by: Guoju Hong, et al.
Published: (2020-03-01)

Dual Oxidase Maturation Factor 1 Positively Regulates RANKL-Induced Osteoclastogenesis via Activating Reactive Oxygen Species and TRAF6-Mediated Signaling
by: Yoon-Hee Cheon, et al.
Published: (2020-09-01)

Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT
by: Guoju Hong, et al.
Published: (2017-01-01)

Activation of Shc1 Allows Oncostatin M to Induce RANKL and Osteoclast Formation More Effectively Than Leukemia Inhibitory Factor
by: Emma Persson, et al.
Published: (2019-05-01)

Berberine Sulfate Attenuates Osteoclast Differentiation through RANKL Induced NF-κB and NFAT Pathways
by: Lin Zhou, et al.
Published: (2015-11-01)

Norlichexanthone purified from plant endophyte prevents postmenopausal osteoporosis by targeting ERα to inhibit RANKL signaling
by: Keqi Wang, et al.
Published: (2021-02-01)

Macrophages Switch to an Osteo‐Modulatory Profile Upon RANKL Induction in a Medaka (Oryzias latipes) Osteoporosis Model
by: Quang Tien Phan, et al.
Published: (2020-11-01)

Carbon Monoxide Inhibits Receptor Activator of NF-κB (RANKL)-Induced Osteoclastogenesis
by: Feng-Jen Tseng, et al.
Published: (2015-07-01)

Daily chemical evodiamine from Chinese prickly ash attenuates osteoclast differentiation through RANKL induced NFAT pathways
by: Lei Jiang, et al.
Published: (2017-10-01)

(−)-Epicatechin 3-O-β-d-allopyranoside prevent ovariectomy-induced bone loss in mice by suppressing RANKL-induced NF-κB and NFATc-1 signaling pathways
by: Hung-Bo Hsiao, et al.
Published: (2017-05-01)

Inhibitory Effect of Cudratrixanthone U on RANKL-Induced Osteoclast Differentiation and Function in Macrophages and BMM Cells
by: Eun-Nam Kim, et al.
Published: (2020-08-01)

(−)-Epigallocatechin-3-Gallate Decreases Osteoclastogenesis via Modulation of RANKL and Osteoprotegrin
by: Shih-Tse Chen, et al.
Published: (2019-01-01)

Placotylene A, an Inhibitor of the Receptor Activator of Nuclear Factor-κB Ligand-Induced Osteoclast Differentiation, from a Korean Sponge Placospongia sp.
by: Hiyoung Kim, et al.
Published: (2014-04-01)

Nrf2 is required for suppressing osteoclast RANKL-induced differentiation in RAW 264.7 cells via inactivating cannabinoid receptor type 2 with AM630
by: Wan Li, et al.
Published: (2020-06-01)

Guizhi-Shaoyao-Zhimu decoction attenuates bone erosion in rats that have collagen-induced arthritis via modulating NF‐κB signalling to suppress osteoclastogenesis
by: Shu-jun Wei, et al.
Published: (2021-01-01)

Ethanol Extract of Atractylodes macrocephala Protects Bone Loss by Inhibiting Osteoclast Differentiation
by: Youn-Hwan Hwang, et al.
Published: (2013-06-01)

Meclizine Prevents Ovariectomy-Induced Bone Loss and Inhibits Osteoclastogenesis Partially by Upregulating PXR
by: Jiachao Guo, et al.
Published: (2017-10-01)

Water Extract of Acer tegmentosum Reduces Bone Destruction by Inhibiting Osteoclast Differentiation and Function
by: Hyunil Ha, et al.
Published: (2014-04-01)

Corrigendum: Meclizine Prevents Ovariectomy-Induced Bone Loss and Inhibits Osteoclastogenesis Partially by Upregulating PXR
by: Jiachao Guo, et al.
Published: (2018-01-01)

Use of Denosumab in Children With Osteoclast Bone Dysplasias: Report of Three Cases
by: Alexander Upfill‐Brown, et al.
Published: (2019-10-01)

Protective Effects of Fermented Oyster Extract against RANKL-Induced Osteoclastogenesis through Scavenging ROS Generation in RAW 264.7 Cells
by: Jin-Woo Jeong, et al.
Published: (2019-03-01)

Glutaredoxin2 isoform b (Glrx2b) promotes RANKL-induced osteoclastogenesis through activation of the p38-MAPK signaling pathway
by: Jeong-Tae Yeon, et al.
Published: (2012-03-01)

Aspirin inhibits RANKL-induced osteoclast differentiation in dendritic cells by suppressing NF-κB and NFATc1 activation
by: Lili Wu, et al.
Published: (2019-12-01)

Clathrin-dependent endocytosis of membrane-bound RANKL in differentiated osteoclasts
by: P. Narducci, et al.
Published: (2010-03-01)

Tart Cherry Prevents Bone Loss through Inhibition of RANKL in TNF-Overexpressing Mice
by: Nicholas Moon, et al.
Published: (2018-12-01)